GLP-1 (Glucagon-Like Peptide 1) plays a pivotal role in regulating blood glucose or blood sugar, promoting weight loss, enhancing cardiovascular health, protecting nerves, and improving gut health. Its multifaceted benefits make it crucial for metabolic and neurological functions.
GLP-1 (Glucagon-Like Peptide 1) is a naturally occurring hormone produced in the gut, specifically in the L-cells of the ileum and colon. It plays a pivotal role in regulating blood glucose levels and appetite control. When we eat, GLP-1 is released into the bloodstream and has several key functions: it stimulates the pancreas to release insulin, which helps lower blood glucose it inhibits the release of glucagon, a hormone that raises blood sugar; it acts on the brain to reduce appetite and increase feelings of fullness, contributing to food intake regulation; and it slows the emptying of the stomach, leading to more gradual nutrient absorption and stabilized blood glucose levels. GLP-1 has become a target for medications used to treat type 2 diabetes mellitus and obesity, as it can help improve blood sugar control and promote weight loss when its effects are mimicked or enhanced.
GLP-1, or Glucagon-Like Peptide 1, regulates blood glucose and appetite through multiple mechanisms. When we eat, GLP-1 is released from the small intestine and stimulates the pancreas to secrete insulin, which in turn helps lower blood glucose levels. It also inhibits glucagon secretion, which prevents the liver from releasing excess glucose into the bloodstream. GLP-1 acts on the brain to reduce appetite and increase the sensation of fullness, helping control food intake. Additionally, it slows down the emptying of the stomach, leading to gradual nutrient absorption and stable blood glucose levels. Overall, GLP-1 plays a vital role in glucose homeostasis and body weight regulation.
GLP-1, or glucagon-like peptide-1, is an incretin hormone produced in the intestines in response to food intake. It has a variety of roles related to metabolism, but one of its most notable effects is its ability to promote feelings of satiety, which can help reduce food intake and thus support weight loss.
GLP-1 exerts its weight loss effects through the following mechanisms:
It’s worth mentioning that while GLP-1 agonists can be effective tools for weight loss, they are best used as part of a comprehensive weight management plan that includes dietary changes, exercise, and other lifestyle modifications. As with all medications, GLP-1 agonists can have side effects, so individuals need to discuss the risks and benefits with their healthcare provider.
A GLP-1 agonist (glucagon-like peptide-1 agonist), also known as GLP 1 RA (glucagon-like peptide-1 receptor agonist), is a class of drugs that mimic the action of the body’s native GLP-1 hormone. GLP-1 is an incretin hormone produced in the intestines in response to food intake, which plays a role in glucose homeostasis by stimulating insulin secretion, inhibiting glucagon release, slowing gastric emptying, and promoting feelings of satiety.
GLP 1 receptor agonists are used primarily in treating type 2 diabetes mellitus to help lower blood sugar levels. This is the reason why they are also called glucose-lowering medications. They have the additional benefits of promoting weight loss and having a favorable effect on cardiovascular risk factors (e.g. heart failure).
Some examples of GLP 1 receptor agonists or GLP 1 drugs include:
It’s worth noting that while they offer many advantages, GLP 1 receptor agonists also come with potential side effects, and it’s essential for patients to discuss these with their healthcare provider.
A GLP-1 analogue is a medication that mimics the action of the naturally occurring hormone glucagon-like peptide-1 (GLP-1). GLP-1 is a hormone that is produced by the intestines and plays a role in regulating blood sugar levels.
GLP-1 analogues are used to treat type 2 diabetes mellitus and obesity. They work by stimulating the pancreas to produce more insulin and slowing down food digestion. This helps to lower blood sugar levels and promote weight loss.
GLP-1 analogues are typically given as a once-weekly injection or once a month. They are generally well-tolerated and have few side effects. However, some people may experience mild side effects such as nausea, vomiting, diarrhea, and abdominal pain.
GLP-1 analogues are an effective treatment for type 2 diabetes and obesity. They can help to improve glycemic control (blood sugar control), promote weight loss, and reduce the risk of cardiovascular disease such as heart failure.
If you are considering taking a GLP-1 analogue, be sure to talk to your doctor about the risks and benefits.
GLP-1 analogues and GLP-1 receptor agonists are not exactly the same thing, but they are very similar.
GLP-1 analogues are synthetic versions of the naturally occurring hormone glucagon-like peptide-1 (GLP-1). GLP-1 is a hormone that is produced by the intestines and plays a role in regulating blood sugar levels and appetite.
GLP-1 receptor agonists are medications that bind to and activate the GLP-1 receptor. This mimics the action of GLP-1 and has the same effects on blood sugar levels and appetite.
In other words, all GLP-1 receptor agonists are GLP-1 analogues, but not all GLP-1 analogues are GLP-1 receptor agonists. For example, some GLP-1 analogues are used for research purposes and are not intended to be used as medications.
GLP-1 supplements are dietary supplements claimed to increase the production or release of the hormone glucagon-like peptide-1 (GLP-1). GLP-1 is a hormone produced by the intestines and plays a role in regulating blood sugar levels and appetite.
GLP-1 supplements are typically made from fiber, herbs, and probiotics. However, limited scientific evidence supports the claims that these supplements can effectively increase GLP-1 levels or have any health benefits.
Some of the most common ingredients in GLP-1 supplements include:
If you are considering taking a GLP-1 supplement, talk to your doctor first. Your doctor can help you determine if a GLP-1 supplement is right for you and can monitor you for any potential side effects.
Glucose-lowering medications such as GLP-1 (Glucagon-like peptide-1) receptor agonists are injectable medications used primarily to manage type 2 diabetes mellitus. They work by mimicking the action of the body’s own GLP-1 hormone, which increases insulin release, reduces glucagon secretion (another hormone that raises blood sugar), and slows stomach emptying. This combination of effects helps lower blood sugar levels in people with type 2 diabetes. However, a known side effect of these medications is significant weight loss.
The significant weight loss effect of GLP-1 receptor agonists has led to interest in their use for obesity management, even in individuals without diabetes. Here are some points to consider about the use of GLP-1 agonists for weight loss in non-diabetic individuals:
In conclusion, GLP-1 receptor agonists can be effective tools for weight loss, even in non-diabetic individuals, but they are just one piece of a comprehensive weight management approach. It’s always essential to consult with a healthcare provider before starting any new medication or weight loss strategy.
No, GLP-1 drugs are not over-the-counter. They are prescription medications used to treat type 2 diabetes mellitus and obesity. GLP-1 drugs work by mimicking the action of the naturally occurring hormone glucagon-like peptide-1 (GLP-1). GLP-1 is a hormone produced by the intestines and regulates blood sugar levels and appetite.
GLP-1 drugs are typically given as a once-weekly injection or once a month. They are generally well-tolerated and have few side effects. However, some people may experience mild side effects such as nausea, vomiting, diarrhea, and abdominal pain.
GLP-1 drugs are an effective treatment for type 2 diabetes and obesity. They can help lower blood sugar, promote weight loss, and reduce the risk of cardiovascular disease.
There is currently only one oral GLP-1 agonist approved by the FDA: oral semaglutide (Rybelsus). This oral medication is approved for treating type 2 diabetes and helps lower blood sugar levels by improving insulin secretion from the pancreas.
However, several other oral GLP-1 agonists are in development, and some are in late-stage clinical trials. These medications are expected to be approved by the FDA in the next few years.
Here are some of the oral GLP-1 agonists in development:
These medications are still in the early stages of development, so it is not yet clear when they will be available to patients.
Oral GLP-1 agonists are a promising new class of medications for the treatment of type 2 diabetes and obesity. They offer a number of advantages over injectable GLP-1 agonists, such as convenience, affordability, and fewer side effects.
If you are interested in learning more about oral GLP-1 agonists, talk to your doctor. They can help you to determine if an oral medication like GLP-1 agonist is right for you.
GLP-1 (glucagon-like peptide 1) and GIP (glucose-dependent insulinotropic polypeptide) are two hormones that are produced in the small intestine in response to food intake. Despite their similarities, there are significant differences between the two. Both hormones help to regulate blood sugar levels and appetite, which in turn achieves blood sugar control and significant weight loss.
Both food intake and blood sugar levels stimulate GLP-1. When blood sugar levels are high, GLP-1 levels also increase. This helps to lower blood sugar levels via slowed gastric emptying, stimulating the release of more insulin, and inhibiting the release of glucagon from the pancreas. GLP-1 also has a role in appetite regulation. It can suppress appetite and lead to weight loss. On the other hand, GIP is stimulated by food intake, but its levels are not affected by blood sugar levels. GIP helps regulate blood sugar levels by stimulating insulin release from the pancreas. GIP also has a role in appetite regulation. It can suppress appetite and lead to weight loss.
The dosage of GLP-1 (Glucagon-Like Peptide 1) receptor agonists can vary depending on the specific medication and individual patient needs. These medications are typically administered via subcutaneous injection, with options such as a once-daily or once-weekly injection. The dosing frequency can be once a day or, for many patients, a more convenient once-weekly injection. The specific dosage and frequency, whether it’s a once-daily or a once-weekly injection, will be determined by a healthcare provider based on factors such as the patient’s medical history, current health status, and the particular GLP-1 agonist being prescribed. Patients must follow their healthcare provider’s dosing instructions carefully, especially when transitioning to a once-weekly injection, and not adjust their dosage without medical guidance to ensure safe and effective management of conditions like type 2 diabetes or obesity.
In addition to assessing blood sugar levels, healthcare providers should also assess cardiovascular outcomes in patients taking GLP-1 receptor agonists. This is because GLP-1 receptor agonists have been shown to reduce the risk of cardiovascular events (e.g. cardiovascular death or nonfatal myocardial infarction) in people with type 2 diabetes.
The following are the administration frequency for popular GLP-1 receptor agonists:
GLP-1 receptor agonists are a class of diabetes drugs that have expanded their indications over the years, owing to their efficacy and safety profile. Here’s a comprehensive list of indications for GLP-1 receptor agonists:
GLP-1 (Glucagon-like peptide-1) receptor agonists are a class of medications primarily used to treat type 2 diabetes mellitus. They function by mimicking the actions of the endogenous incretin hormone GLP-1, which increases insulin release and decreases glucagon release in a glucose-dependent manner, thus aiding in blood glucose control.
GLP-1 receptor agonists can be classified into two broad categories based on their chemical structure: peptide-based and non-peptide-based (small molecule) agonists.
These are analogs of the native GLP-1 molecule or are peptides that have similar action on the GLP-1 receptor. They are usually injected subcutaneously.
These are smaller, non-peptide molecules that activate the GLP-1 receptor. Their development is challenging due to the complexity of mimicking the actions of a large peptide with a small molecule. As of my last update in January 2022, there weren’t any non-peptide GLP-1 receptor agonists approved for clinical use, but research in this area is ongoing.
Pros (theoretical, based on potential advantages):
In summary, while peptide-based GLP-1 receptor agonists have established their place in the treatment of type 2 diabetes, the development and potential approval of non-peptide agonists might offer additional options for treatment with different routes of administration and pharmacokinetic profiles. As always, the selection of the right drug should be based on individual patient needs, potential benefits, and risks.
GLP-1 receptor agonists are not recommended for patients with the following:
GLP-1 receptor agonist side effects are very uncommon. There have been some side effects associated with its use wherein the patient had one of the issues listed below at some point while being on GLP-1 receptor agonists. However, these side effects weren’t confirmed to be associated with the treatment and could have been a coincidence and not related to the use of GLP-1 receptor agonists. Despite this, it was listed as a side effect associated with GLP-1 receptor agonist therapy even though these associated side effects are very uncommon.
It’s essential for individuals using GLP-1 receptor agonists to discuss potential side effects with their healthcare providers and monitor their response to the medication closely, including assessing cardiovascular outcomes. When considering these drugs, it’s also essential to take into account their cardiovascular safety.
Traditional peptide-based medications like incretin therapies face challenges when taken orally due to poor absorption in the body. Presently, available incretin therapies are primarily administered via injections or in the form of a pill known as semaglutide. However, oral absorption of these therapies is limited, with only a small fraction (0.4% to 1.0%) being effectively absorbed when taken on an empty stomach. Fortunately, researchers have identified an alternative approach that does not rely on peptides, leading to enhanced oral efficacy in incretin therapies. One such breakthrough is the non-peptide medication known as orforglipron, which demonstrates significantly improved oral absorption rates (20% to 40%) compared to semaglutide. Although oral non-peptide glucagon-like peptide-1 receptor agonist is not a peptide, it is included in this section because it works as an agonist to a peptide receptor (glucagon-like-peptide-1 receptor).
GLP-1 drugs are a class of medications that mimic the action of the hormone glucagon-like peptide-1 (GLP-1). GLP-1 is a naturally occurring hormone that helps to regulate blood sugar levels, appetite, and has notable cardiovascular effects, and carries a low risk of side effects for most people.
GLP-1 drugs can be used to help people lose weight by reducing appetite and increasing feelings of fullness, offering a reduced risk of overeating.
Yes, GLP-1 drugs can improve both systolic blood pressure and diastolic blood pressure. GLP-1 drugs work by reducing appetite and increasing feelings of fullness, which can lead to weight loss, a low-risk factor for improved health. Weight loss can lower both systolic and diastolic blood pressure. GLP-1 drugs can also improve blood pressure by reducing insulin resistance. Insulin resistance can lead to high blood sugar levels, which can damage blood vessels and increase the serious risk of heart disease and stroke. GLP-1 drugs can help to lower blood sugar levels and improve insulin sensitivity, which can lead to lower blood pressure.
Ozempic is a brand name for the GLP-1 receptor agonist semaglutide. Semaglutide is one of the most effective GLP-1 drugs for weight loss.
No, GLP-1 drugs cannot be bought over the counter. They are prescription medications that must be prescribed by a healthcare professional.
The following drugs are used for GLP-1:
The most common GLP-1 agonists are:
The following GLP-1 drugs are approved for weight loss:
The best GLP-1 for weight loss depends on individual factors, such as the patient’s medical history and weight loss goals. However, semaglutide (Ozempic) is generally considered to be the most effective GLP-1 for weight loss.
Semaglutide is the generic name for Ozempic. Ozempic is a brand-name medication that contains semaglutide. Therefore, semaglutide and Ozempic are the same medication.
Semaglutide (Ozempic) is generally considered to be the most effective GLP-1 for weight loss.
To qualify for GLP-1 for weight loss, you must meet certain criteria, such as:
Yes, you can take GLP-1 if you are not diabetic. GLP-1 drugs are approved for weight loss in people with overweight or obesity, even if they do not have diabetes.
GLP-1 drugs can be used for long-term weight loss. However, it is important to talk to your doctor about how long you should take GLP-1 for weight loss.
GLP-1 RA drugs are glucagon-like peptide-1 receptor agonists. GLP-1 RA drugs are a type of medication that mimics the action of the hormone glucagon-like peptide-1 (GLP-1).
GLP-1 RA drugs can be used to help people lose weight by reducing appetite and increasing feelings of fullness.
GLP-1 RA drugs are generally more effective for weight loss than metformin. However, metformin is a less expensive medication and has fewer side effects.
The American Diabetes Association suggests that metformin is the primary recommended treatment for type 2 diabetes, particularly in cases of persistent hyperglycemia. But, for those who cannot tolerate or have contraindications to metformin, adding a GLP-1 analog may be an option to consider.
GLP-1 works by reducing appetite and increasing feelings of fullness. GLP-1 also slows down the emptying of the stomach, which helps to reduce calorie intake.
The serious risk of side effects or adverse events of GLP-1 includes:
The most common side effect of GLP-1 is nausea. Other common side effects include vomiting, diarrhea, constipation, and abdominal pain.
GLP-1 drugs can be expensive, have some side effects, and carry a serious risk for some individuals. They also require regular injections.
People who should avoid GLP-1 include:
GLP-1 analogues are medications that mimic the action of the hormone glucagon-like peptide-1 (GLP-1). Some examples of GLP-1 analogues include:
Yes, Ozempic is a GLP-1 analogue.
Yes, you can get Ozempic for weight loss without diabetes. Ozempic is approved for weight loss in people with overweight or obese, even if they do not have diabetes.
The following GLP-1 agonists are approved for weight loss without diabetes:
There are no supplements that have been proven to increase GLP-1 levels. However, some foods and herbs may help to increase GLP-1 levels, such as:
You can increase your GLP-1 levels naturally by making lifestyle changes, such as:
If you are considering taking GLP-1 for weight loss, talk to your doctor to see if it is right for you. It’s important to seek medical care and understand any associated low-risk or serious risks before making decisions. Always prioritize medical care when considering new treatments.
At the age of 60, I look and feel better than I ever have in my entire life! Switching my health program and hormone replacement therapy regimen over to Genemedics was one of the best decisions I’ve ever made in my life! Genemedics and Dr George have significantly improved my quality of life and also dramatically improved my overall health. I hav...
Nick Cassavetes ,60 yrs old Movie Director (“The Notebook”, “John Q”, “Alpha Dog”), Actor and Writer
I am now in my mid-sixties and feel better than I did in my 20’s. Many people have commented that I actually look 20 years younger since I started the program at Genemedics.
Calling Dr. George has proven to be one of the best decisions I have made in my life. Doctors and society convince us that developing various health issues and negative sy...
Pamela Hill ,66 yrs old
Call 800-277-4041 for a Free Consultation
Genemedics® Health Institute is a global premier institute dedicated to revolutionizing health and medicine through healthy lifestyle education, guidance and accountability in harmony with functional medicine. Our physician-supervised health programs are personally customized to help you reach your health and fitness goals while looking and feeling better than ever.
STEPS AWAY FROM A YOUNGER. HEALTHIER YOU!
Call 800-277-4041 for a Free Consultation
What to expect during your consultation: